Evolution of surgical treatment of primary hyperparathyroidism in patients with multiple endocrine neoplasia type 2A

Endocrine Practice

Volumn 17, Issue 1, 2011, Pages 7-15

  Scholten, Anouk ^a   Schreinemakers, Jennifer M J ^a,b   Pieterman, Carolina R C ^a   Valk, Gerlof D ^a   Vriens, Menno R ^a   Borel Rinkes, Inne H M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b AMPHIA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; PARATHYROID HORMONE;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; COHORT ANALYSIS; FEMALE; HUMAN; HYPOPARATHYROIDISM; MALE; MINIMALLY INVASIVE SURGERY; MULTIPLE ENDOCRINE NEOPLASIA; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PREOPERATIVE EVALUATION; PRIMARY HYPERPARATHYROIDISM; RETROSPECTIVE STUDY; SYSTEMATIC REVIEW; THYROIDECTOMY; TREATMENT OUTCOME;

ADULT; COHORT STUDIES; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; PARATHYROIDECTOMY; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79952374754     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP10050.OR     Document Type: Article

References (21)

1. Lips CJ, Landsvater RM, Höppener JW, et al. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A. N Engl J Med. 1994;331:828-835. (Pubitemid 24289709)
2. Steiner AL, Goodman AD, Powers. Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing's disease: Multiple endocrine neoplasia, type 2. Medicine (Baltimore). 1968;47:371-409.
3. Carty SE, Helm AK, Amico JA, et al. The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1. Surgery. 1998;124:1106-1113.
4. Pieterman CR, Schreinemakers JM, Koppeschaar HP, et al. Multiple endocrine neoplasia type 1 (MEN1): Its manifestations and effect of genetic screening on clinical outcome. Clin Endocrinol (Oxf). 2009;70:575-581.
5. Kraimps JL, Denizot A, Carnaille B, et al. Primary hyperparathyroidism in multiple endocrine neoplasia type IIa: Retrospective French multicentric study. Groupe d'Etude des Tumeurs a Calcitonine (GETC, French Calcitonin Tumors Study Group), French Association of Endocrine Surgeons. World J Surg. 1996;20:808-812.
6. Raue F, Kraimps JL, Dralle H, et al. Primary hyperparathyroidism in multiple endocrine neoplasia type 2A. J Intern Med. 1995;238:369-373.
7. Herfarth KK, Bartsch D, Doherty GM, Wells SA Jr, Lairmore TC. Surgical management of hyperparathyroidism in patients with multiple endocrine neoplasia type 2A. Surgery. 1996;120:966-973.
8. Dotzenrath C, Cupisti K, Goretzki PE, et al. Long-term biochemical results after operative treatment of primary hyperparathyroidism associated with multiple endocrine neoplasia types I and IIa: Is a more or less extended operation essential? Eur J Surg. 2001;167:173-178. (Pubitemid 32231953)
9. Dotzenrath C, Goretzki PE, Roher HD. Surgery of primary hyperparathyroidism in patients with multiple gland disease: The Dusseldorf experience. Acta Chir Austriaca. 1994;26:47-49.
10. Dralle H, Scheumann GFW. How to handle the parathyroid glands in multiple endocrine neoplasia type I (MEN I) and type II (MEN II)? Surgical approach to uniglandular versus multiglandular disease in hereditary primary hyperparathyroidism. Acta Chir Austriaca. 1994;26:35-38.
11. van Heerden JA, Kent RB 3rd, Sizemore GW, Grant CS, ReMine WH. Primary hyperparathyroidism in patients with multiple endocrine neoplasia syndromes. Surgical experience. Arch Surg. 1983;118:533-536.
12. Kraimps JL, Duh QY, Demeure M, Clark OH. Hyperparathyroidism in multiple endocrine neoplasia syndrome. Surgery. 1992;112:1080-1086.
13. O'Riordain DS, O'Brien T, Grant CS, Weaver A, Gharib H, van Heerden JA. Surgical management of primary hyperparathyroidism in multiple endocrine neoplasia types 1 and 2. Surgery. 1993;114:1031-1037.
14. Smit PC, Borel Rinkes IH, van Dalen A, van Vroonhoven TJ. Direct, minimally invasive adenomectomy for primary hyperparathyroidism: An alternative to conventional neck exploration? Ann Surg. 2000;231:559-565.
15. Lewis PD. Surgical Pathology of the Parathyroids in Primary and Secondary Hyperparathyroidism. In: Lynn J, Bloom SR, eds. Surgical Endocrinology. Oxford, PA: Butterworth-Heinemann Ltd, 1993: 331-393.
16. Oxford Centre for Evidence-based Medicine Levels of Evidence (May 2001). Available at: http://www.cebm.net/index.aspx?o=1047. Accessed April 10, 2010.
17. Cance WG, Wells SA Jr. Multiple endocrine neoplasia. Type IIa. Curr Probl Surg. 1985;22:1-56.
18. Norman J. Recent trends becoming standard of care yielding smaller, more successful operations at a lower cost. Otolaryngol Clin North Am. 2004;37:683-688. (Pubitemid 38950680)
19. Mullan BP. Nuclear medicine imaging of the parathyroid. Otolaryngol Clin North Am. 2004;37:909-939. (Pubitemid 38950697)
20. Irvin GL 3rd, Prudhomme DL, Deriso GT, Sfakianakis G, Chandarlapaty SK. A new approach to parathyroidectomy. Ann Surg. 1994;219:574-579.
21. Shindo M. Intraoperative rapid parathyroid hormone monitoring in parathyroid surgery. Otolaryngol Clin North Am. 2004;37:779-787. (Pubitemid 38950687)